Equities Analysts Offer Predictions for Chemours Q1 Earnings

The Chemours Company (NYSE:CC) – Analysts at Zacks Research decreased their Q1 2026 earnings per share (EPS) estimates for Chemours in a research report issued on Wednesday, March 4th. Zacks Research analyst Team now forecasts that the specialty chemicals company will earn ($0.09) per share for the quarter, down from their previous estimate of $0.20. The consensus estimate for Chemours’ current full-year earnings is $2.03 per share. Zacks Research also issued estimates for Chemours’ Q4 2026 earnings at $0.13 EPS, FY2026 earnings at $1.06 EPS, Q3 2027 earnings at $0.52 EPS and FY2027 earnings at $1.97 EPS.

Chemours (NYSE:CC) last posted its quarterly earnings results on Thursday, February 19th. The specialty chemicals company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.01 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Chemours had a positive return on equity of 41.75% and a negative net margin of 6.41%.The firm’s revenue was down 2.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.09 EPS.

A number of other equities analysts also recently weighed in on CC. Jefferies Financial Group reaffirmed a “hold” rating and set a $17.00 price target on shares of Chemours in a research note on Monday, February 23rd. Truist Financial upped their price objective on Chemours from $18.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, January 21st. Mizuho increased their target price on Chemours from $17.00 to $21.00 and gave the stock an “outperform” rating in a research report on Thursday. Royal Bank Of Canada reissued an “outperform” rating and set a $18.00 price target on shares of Chemours in a research report on Friday, January 16th. Finally, Morgan Stanley upped their price target on Chemours from $15.00 to $17.00 and gave the stock an “equal weight” rating in a research note on Monday, February 23rd. Five research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, Chemours has an average rating of “Hold” and a consensus price target of $18.40.

Chemours Price Performance

Chemours stock opened at $16.44 on Monday. Chemours has a 1 year low of $9.13 and a 1 year high of $21.85. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.85 and a current ratio of 1.78. The firm has a 50 day moving average price of $16.38 and a 200 day moving average price of $14.74. The company has a market cap of $2.47 billion, a price-to-earnings ratio of -6.63 and a beta of 1.60.

Institutional Investors Weigh In On Chemours

Hedge funds have recently modified their holdings of the stock. Cooper Creek Partners Management LLC purchased a new position in Chemours in the 3rd quarter worth approximately $63,103,000. Scopia Capital Management LP boosted its stake in shares of Chemours by 71.7% in the second quarter. Scopia Capital Management LP now owns 3,355,261 shares of the specialty chemicals company’s stock valued at $38,418,000 after purchasing an additional 1,401,539 shares during the period. State Street Corp grew its holdings in Chemours by 22.7% during the 2nd quarter. State Street Corp now owns 6,114,328 shares of the specialty chemicals company’s stock valued at $70,009,000 after purchasing an additional 1,131,682 shares in the last quarter. Wolf Hill Capital Management LP acquired a new stake in Chemours during the 3rd quarter valued at $17,025,000. Finally, Sona Asset Management US LLC increased its stake in Chemours by 176.9% during the 4th quarter. Sona Asset Management US LLC now owns 1,651,275 shares of the specialty chemicals company’s stock worth $19,469,000 after buying an additional 1,055,000 shares during the period. 76.26% of the stock is currently owned by hedge funds and other institutional investors.

Chemours Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Stockholders of record on Friday, February 27th will be paid a $0.0875 dividend. The ex-dividend date is Friday, February 27th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.1%. Chemours’s dividend payout ratio (DPR) is -14.11%.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.